Ramona Doyle

Chief Executive Officer bei The MAVEN Project

65 Jahre

Consumer Services

Health Technology

Government

Profil

Zurzeit ist Ramona Doyle Chief Medical Officer von Recursion Pharmaceuticals, Inc.

Unternehmen	Position	Beginn
The MAVEN Project	Chief Executive Officer	01.09.2020
The University of California, San Francisco	Corporate Officer/Principal	01.10.2011

Unternehmen	Position	Ende
RECURSION PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	07.06.2022
Blade Therapeutics, Inc. Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	01.05.2018
California Institute for Regenerative Medicine	Corporate Officer/Principal	01.07.2016
Stanford University School of Medicine	Corporate Officer/Principal	01.01.2008

University of Oxford	Graduate Degree
Sewanee-The University of the South	Undergraduate Degree
Emory University School of Medicine	Doctorate Degree

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Börsennotierte Unternehmen	1
RECURSION PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	3
California Institute for Regenerative Medicine	Government
Blade Therapeutics, Inc. Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.	Commercial Services
The MAVEN Project